Mrs. Lucia Csaszar, M.S.P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 145 Route 22, Suite 201, Pawling, NY 12564 Phone: 845-855-5214 Fax: 845-855-1977 |
Timothy Chamberlain, PT,MHSC, MTC Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 4 Oak St Ste B, Pawling, NY 12564 Phone: 845-855-2661 Fax: 845-855-2672 |
Chamberlain Physical Therapy Pc Physical Therapist Medicare: Medicare Enrolled Practice Location: 4 Oak St Ste B, Pawling, NY 12564 Phone: 845-855-2661 Fax: 845-855-2672 |
Ms. Jo Anne Dodd Pardee, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 145 Route 22, Suite 201, Pawling, NY 12564 Phone: 845-855-5214 Fax: 845-855-1977 |
Mrs. Melanie Opinion Bernarte, R.P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 9 Reservoir Rd., Pawling, NY 12564 Phone: 845-855-5700 |
Elizabeth Weiss, PT, FOC Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 4 Oak St Ste B, Pawling, NY 12564 Phone: 845-855-2661 Fax: 845-855-2672 |
News Archive
New research from the Bradley Hasbro Children's Research Center may help clinicians better predict how a child with obsessive compulsive disorder (OCD) will respond to some of the most commonly used treatment approaches. The findings, published in the October issue of the Journal of the American Academy of Child and Adolescent Psychiatry, could help guide important clinical decisions about the best intervention for children with this often debilitating anxiety disorder.
PolyMedix, Inc. (www.polymedix.com), an emerging biotechnology company focused on developing new therapeutic drugs to treat infectious diseases and acute cardiovascular disorders, provided an overview of its 2010 clinical milestones in a presentation by President & C.E.O., Nicholas Landekic at the 2010 BIO CEO & Investor Conference.
Researchers at Weill Cornell Medical College have shown that it is possible to immunize mammals to control fertility. They say their technique could possibly be used on other mammals - including humans - because fertility hormones and their receptors are species-non-specific and are similar in both females and males. For pets, the technique could be an alternative to castration and adverse effects of hormone administration.
Santaris Pharma A/S, a privately-held biopharmaceutical company focused on developing RNA-based drugs targeted to disease-related mRNAs and microRNAs, today announced it has established operations in the United States. Internally and through its partners, the Company has a robust drug development pipeline including programs to treat metabolic disorders, infectious and inflammatory diseases, cancer and rare genetic disorders.
› Verified 5 days ago